ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "axial spondyloarthritis"

  • Abstract Number: 1164 • 2016 ACR/ARHP Annual Meeting

    Impact of E-Learning on Knowledge, Self-Efficacy and Exercise Behaviours of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial

    Laura Passalent1,2, Rita Kang3, Daeria Lawson4, Christopher Hawke1,5, Ahmed Omar6,7, Arane Thavaneswaran4, Nigil Haroon8,9 and Robert D Inman7,10, 1Allied Health, Toronto Western Hospital, Toronto, ON, Canada, 2Physical Therapy, University of Toronto, Toronto, ON, Canada, 3Patient and Family Education, Toronto Western Hospital, Toronto, ON, Canada, 4Toronto Western Hospital, Toronto, ON, Canada, 5Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, 6Rheumatology, University of Toronto, Toronto, ON, Canada, 7Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, 8Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 9Medicine, Rheumatology, University of Toronto, Toronto, ON, Canada, 10University of Toronto, Toronto, ON, Canada

    Background/Purpose:  There is a growing body of evidence to support the effectiveness of education programs for patients with arthritis. Despite this, there has been little development…
  • Abstract Number: 1240 • 2016 ACR/ARHP Annual Meeting

    A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis

    Nina Mars1, Anne M Kerola2, Markku J Kauppi3,4, Outi Elonheimo5,6, Santeri Huvinen5,6 and Tuulikki Sokka-Isler7,8, 1University of Helsinki, Helsinki, Finland, 2Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 3School of Medicine, University of Tampere, Tampere, Finland, 4Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland, 5Network of Academic Health Centres, Department of Medicine, University of Helsinki, Helsinki, Finland, 6FCG Finnish Consulting Group Ltd., Helsinki, Finland, 7Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland, 8RAID working group for EULAR, Zurich, Switzerland

    Background/Purpose: Rheumatoid arthritis (RA) is associated with high healthcare costs, but little is known about how the costs compare to other chronic rheumatic diseases. We…
  • Abstract Number: 1292 • 2016 ACR/ARHP Annual Meeting

    Performance of 18fluoride Sodium Positron Emission Tomography with Computed Tomography to Assess Inflammatory and Structural Sacroiliitis Respectively on Magnetic Resonance Imaging and Computed Tomography in Axial Spondyloarthritis

    Marie Raynal1, ouichka remy2, Julian Melchior1, Isabelle Chary-Valckenaere3, Willy Ngueyon Sime4, Walter P. Maksymowych5, Robert G. Lambert6 and Damien Loeuille3, 1Rheumatology, CHRU Nancy, Nancy, France, 2rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 3Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 4University of Lorraine, Nancy, France, 5Medicine, University of Alberta, Edmonton, AB, Canada, 6Radiology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: to assess increased SIJ uptakes on 18-FNa (an osteoblastic tracer) PET/CT according to a qualitative and quantitative approach and to compare with MRI SIJ…
  • Abstract Number: 1667 • 2016 ACR/ARHP Annual Meeting

    Diagnostic Value of Anti-CD74 Antibodies in Axial Spondyloarthritis: Results from a Population with Low HLA-B27 Prevalence Background

    Nelly Ziade1, Fouad Fayad1, Iyad Mallak2, Georges Merheb3, Torsten Witte4 and Xenofon Baraliakos5, 1Rheumatology, Hotel Dieu de France Hospital and Saint Joseph University, Beirut, Lebanon, 2Radiology, Hotel-Dieu de France and Saint-Joseph University, Beirut, Lebanon, 3Internal Medicine, Notre Dame des Secours University Hospital, Jbeil, Lebanon, 4Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 5Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: Axial spondyloarthritis (axSpA) is still frequently diagnosed late and its pathogenesis is still unclear. Although a strong genetic association of axSpA with HLA-B27 is…
  • Abstract Number: 1731 • 2016 ACR/ARHP Annual Meeting

    Disease Burden and Impact of Certolizumab Pegol Treatment on Workplace and Household Productivity Across Working Age Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis Patients

    Arthur F. Kavanaugh1, Philip J. Mease2, Oana Purcaru3 and Désirée van der Heijde4, 1Division of Rheumatology, Allergy, and Immunology, UC San Diego School of Medicine, La Jolla, CA, 2Swedish Medical Center and University of Washington, Seattle, WA, 3208 Bath Road, UCB Pharma, Slough, United Kingdom, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA), can impact…
  • Abstract Number: 1732 • 2016 ACR/ARHP Annual Meeting

    Articular and Axial Involvement Differences in Psoriatic Arthritis Patients Treated with Golimumab in Canadian Real-World Practice

    Majed M. Khraishi1, Proton Rahman2, Alexander Tsoukas3, Suneil Kapur4, Milton F. Baker5, Niall Jones6, Michael Starr7, Emmanouil Rampakakis8, Eliofotisti Psaradellis9, Karina Maslova10, Francois Nantel11, Allen J Lehman10, Cathy Tkaczyk12 and Brendan Osborne12, 1Nexus Clinical Research, St Johns, NF, Canada, 2Rheumatology, St Claires Mercy Hospital, St Johns, NF, Canada, 3McGill University, Montreal, QC, Canada, 4University of Ottawa, 139 Greenbank Rd, Suite 203, ON, Canada, 5VIHA, Victoria, BC, Canada, 6University of Alberta, Edmonton, AB, Canada, 7McGill University, Pointe-Claire, QC, Canada, 8JSS Medical Research, St-Laurent, QC, Canada, 9JSS Medical Research, Montreal, QC, Canada, 10Janssen Inc., Toronto, ON, Canada, 1119 Green belt Dr, Janssen Inc., Toronto, ON, Canada, 12Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose: Psoriatic arthritis (PsA) is a complex rheumatic disease with severity that ranges from mild to severe. The mild form of PsA can be referred…
  • Abstract Number: 2731 • 2016 ACR/ARHP Annual Meeting

    Illness Perceptions and Health-Related Quality of Life in Patients with Axial Spondyloarthritis and Other Forms of Chronic Back Pain in the Spondyloarthritis Caught Early (SPACE)-Cohort

    Miranda van Lunteren1, Pauline Bakker1, Margreet Scharloo2, Ad Kaptein3, Zineb Ez-Zaitouni1, Camilla Fongen4, Robert Landewé5, Maikel van Oosterhout6, Mariagrazia Lorenzin7, Désirée van der Heijde1 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Medical Psychology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 6Rheumatology, Groene Hart Ziekenhuis, Gouda, Netherlands, 7Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy

    Background/Purpose: Knowledge about the impact of illness perceptions on health-related quality of life (HRQoL) in patients with axial Spondyloarthritis (axSpA) and other forms of chronic…
  • Abstract Number: 675 • 2016 ACR/ARHP Annual Meeting

    Association Between Structural Lesions in the Sacroiliac Joints and Spinal Inflammatory Lesions in Patients with Non-Radiographic Axial Spondyloarthritis

    Maxime Dougados1, Robert G Lambert2, Stephanie Wichuk3, Jean-Claude Becker4, Jack F Bukowski5, Heather Jones6, Lisa Marshall6, Annette Szumski7 and Walter Maksymowych3, 1Rheumatology, Paris Descartes University, Paris, France, 2Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 3Medicine, University of Alberta, Edmonton, AB, Canada, 4Becker Clinical Research Consulting, New York, NY, 5Clinical Affairs, Pfizer, Collegeville, PA, 6Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 7inVentiv Health, Princeton, NJ

    Background/Purpose: The relevance of structural lesions in non-radiographic axial SpA (nr-axSpA) is unclear, particularly without signs of MRI inflammation. In a post hoc analysis we…
  • Abstract Number: 2740 • 2016 ACR/ARHP Annual Meeting

    Cam Type Femoroacetabular Impingement Morphology Is More Frequent in Patients with Axial Spondyloarthritis

    Servet Akar1, Ozgur Tosun2, Dilek Solmaz3, Gokay Karaca2, Aliye Tosun4, Mustafa Ozman5 and Fatih Esat Topal6, 1Department of Rheumatology, İzmir Katip Çelebi University, School of Medicine, İzmir, Turkey, İzmir, Turkey, 2Radiology, Izmir Katip Celebi University School of Medicine, izmir, Turkey, 3Rheumatology, Izmir Katip Celebi University School of Medicine, izmir, Turkey, 4physical therapy and rehabilitation, Izmir Katip Celebi University School of Medicine, izmir, Turkey, 5Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, 6Emergency Medicine, Izmir Katip Celebi University School of Medicine, Izmir, Turkey

    Background/Purpose: Femoroacetabular impingement (FAI) is characterized by early pathologic contact of the proximal femur with the acetabulum. Pincer impingement is the acetabular cause of FAI.Whereas…
  • Abstract Number: 687 • 2016 ACR/ARHP Annual Meeting

    Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Atul A. Deodhar1, Maxime Dougados2, Robert Landewé3, Joachim Sieper4, Walter Maksymowych5, Martin Rudwaleit6, Filip van Den Bosch7, Jürgen Braun8, Philip J Mease9, Alan Kivitz10, Jessica Walsh11, Owen Davies12, Bengt Hoepken13, Luke Peterson14 and Désirée van der Heijde15, 1Divison of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, OR, 2Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, 3Academic Medical Center, Amsterdam and Zuyderland Medical Center, Heerlen, Netherlands, 4Rheumatology Department, Charité – University Medicine Berlin, Berlin, Germany, 5Department of Medicine, University of Alberta, Edmonton, AB, Canada, 6Klinikum Bielefeld and Charité – University Medicine Berlin, Berlin, Germany, 7University Hospital Ghent, Ghent, Belgium, 8Rheumazentrum Ruhrgebiet, Herne, Germany, 9Swedish Medical Center and University of Washington, Seattle, WA, 10Altoona Center for Clinical Research, Duncansville, PA, 11Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, UT, 12UCB Pharma, Slough, United Kingdom, 13UCB Pharma, Monheim, Germany, 14UCB Pharma, Raleigh, NC, 15Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: RAPID-axSpA (NCT01087762) investigated the efficacy and safety of certolizumab pegol (CZP) in patients (pts) with axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic…
  • Abstract Number: 2745 • 2016 ACR/ARHP Annual Meeting

    Adult Axial Spondyloarthritis Screening and Referral Practices Amongst Primary Care Physicians, Physiotherapists, Chiropractors and Nurse Practitioners:  Results from a Qualitative Study

    Laura Passalent1,2, Leslie Soever2,3, Kathleen Bednis1, Christopher Hawke1,4, Andrew Bidos5,6, Jeff Bloom7,8, Y. Raja Rampersaud6,8, Nigil Haroon9,10 and Robert D Inman8,9, 1Allied Health, Toronto Western Hospital, Toronto, ON, Canada, 2Physical Therapy, University of Toronto, Toronto, ON, Canada, 3MSK, Geriatrics and Cardiac Rehab Programs, University Health Network, Toronto, ON, Canada, 4Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, 5Health Quality Programs - ISAEC, University Health Network, Toronto, ON, Canada, 6Orthopaedics, Toronto Western Hospital, Toronto, ON, Canada, 7Family Medicine, Toronto Western Hospital, Toronto, ON, Canada, 8University of Toronto, Toronto, ON, Canada, 9Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, 10Rheumatology, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose:  For the axial spondyloarthritis (SpA) population, early recognition is crucial in preventing major morbidity. Despite this, there exists an unacceptably long delay between the…
  • Abstract Number: 688 • 2016 ACR/ARHP Annual Meeting

    Spondyloarthritis Research Consortium of Canada (SPARCC) Baseline MRI SI Joint Score ≥2 Better Predicts Response to Golimumab Than Does Assessment of Spondyloarthritis International Society (ASAS) MRI Positivity in Nonradiographic Axial Spondyloarthritis

    Walter Maksymowych1, Anjela Tzontcheva2, George Philip2, Gina Bergman2, Susan Huyck2 and Sean P. Curtis2, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Merck & Co., Inc., Kenilworth, NJ

    Background/Purpose: Golimumab (GLM) was shown to be effective for nonradiographic axial spondyloarthritis (nr-axSpA) in a randomized, double-blind, placebo-controlled, phase 3 study (GO-AHEAD; NCT01453725).1 The SPondyloArthritis…
  • Abstract Number: 2754 • 2016 ACR/ARHP Annual Meeting

    Self-Reported Physical Activity Questionnaire in Axial Spondyloarthritis: Modification of the Squash

    Fiona Maas1, Anna Jetske Baron1,2, Freke Wink3, Reinhard Bos3, Yvo Kamsma2, Hendrika Bootsma4, Suzanne Arends1,3 and Anneke Spoorenberg1,3, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Center for Human Movement Sciences, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology, Medical Center Leeuwarden, Leeuwarden, Netherlands, 4Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose:  Improvement of physical function and physical activity are important goals in the management of axial spondyloarthritis (axSpA). Although physical function is included in the…
  • Abstract Number: 697 • 2016 ACR/ARHP Annual Meeting

    Does Axial Spondyloarthritis Phenotype Correlate with Imaging Morphotype?

    Xenofon Baraliakos1, Annette Szumski2, Heather Jones3 and Lianne S. Gensler4, 1Rheumazentrum, Ruhr University, Bochum, Germany, 2inVentiv Health, Princeton, NJ, 3Inflammation & Immunology, Pfizer, Collegeville, PA, 4Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Traditionally, radiographic imaging was used to describe morphological differences between various types of axial SpA (axSpA). MRI has advanced understanding of disease, enabled earlier…
  • Abstract Number: 2779 • 2016 ACR/ARHP Annual Meeting

    Better Health-Related Quality of Life and Work Capacity in Patients Achieving Inactive Disease and Clinical Response in Patients with Non-Radiographic Axial Spondyloarthritis

    Maxime Dougados1, Desiree van der Heijde2, Wen-Chan Tsai3, Diego Saaibi4, Randi Bonin5, Lisa Marshall6, Heather Jones7, Ronald Pedersen8, Bonnie Vlahos9 and Miriam Tarallo10, 1Rheumatology, Paris Descartes University, Paris, France, 2Leiden University Medical Center, Leiden, Netherlands, 3Kaohsiung Medical University, Kaohsiung City, Taiwan, 4MEDICITY S.A.S, Bucaramanga, Colombia, 5Clinical Affairs, Pfizer, Collegeville, PA, 6Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 7Inflammation & Immunology, Pfizer, Collegeville, PA, 8Department of Biostatistics, Pfizer, Collegeville, PA, 9GIPB - Clinical Sciences, Pfizer, Collegeville, PA, 10GHV, Pfizer, Rome, Italy

    Background/Purpose: Few studies have evaluated the relationship between disease activity/clinical response and patient-reported outcomes (PROs) of pain, fatigue, health-related quality of life (HRQoL), and work…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology